Europska Unija - hrvatski - EMA (European Medicines Agency)

mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

instituto grifols, s.a., c/can guasch, 2, pol. ind. levante, parets del valles, barcelona, Španjolska - albumin, ljudski - otopina za infuziju - urbroj: 1000 ml otopine za infuziju sadrži 200 g ukupnih proteina, od čega je najmanje 95% ljudski albumin bočica od 10 ml sadrži 2 g ljudskog albumina boca od 50 ml sadrži 10 g ljudskog albumina boca od 100 ml sadrži 20 g ljudskog albumina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

instituto grifols, s.a., c/can guasch, 2, pol. ind. levante, parets del valles, barcelona, Španjolska - albumin, ljudski - otopina za infuziju - urbroj: 1000 ml otopine za infuziju sadrži 50 g ukupnih proteina, od čega je najmanje 95% ljudski albumin boca od 100 ml sadrži 5 g ljudskog albumina boca od 250 ml sadrži 12.5 g ljudskog albumina boca od 500 ml sadrži 25 g ljudskog albumina

Europska Unija - hrvatski - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

iceberg international trading d.o.o, zagreb - uređaj za angiografiju i kardiografiju

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

elektroničar d.o.o. karlovačka cesta 26/a 10000 zagreb -

Hrvatska - hrvatski - Ecolab

ecolab deutschland gmbh -

Europska Unija - hrvatski - EMA (European Medicines Agency)

pfizer europe ma eeig - crizotinib - karcinom, ne-malih stanica pluća - antineoplastična sredstva - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - ginkgo biloba, popis - filmom obložena tableta - 80 mg/1 tableta - 1 filmom obložena tableta sadrži: 80 mg suhog ekstrakta lista ginka (3567:1), rastvarač za ekstrakciju aceton 60%(m/m)

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - ginkgo biloba, popis - filmom obložena tableta - 80 mg/1 tableta - 1 filmom obložena tableta sadrži: 80 mg suhog ekstrakta lista ginka (3567:1), rastvarač za ekstrakciju aceton 60%(m/m)